Free Access
Med Sci (Paris)
Volume 32, Number 11, Novembre 2016
Le microbiote : cet inconnu qui réside en nous
Page(s) 1019 - 1022
Section Nouvelles
Published online 23 December 2016
  1. Weigelt B, Peterse JL, van’t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005 ; 5 : 591–602. [CrossRef] [PubMed] [Google Scholar]
  2. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013 ; 501 : 346–354. [CrossRef] [PubMed] [Google Scholar]
  3. Turtoi A, De Pauw E, Castronovo V. Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapies. Am J Pathol 2011 ; 178 : 12–18. [CrossRef] [PubMed] [Google Scholar]
  4. Turtoi A, Dumont B, Greffe Y, et al. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. J Proteome Res 2011 ; 10 : 3160–3182. [CrossRef] [PubMed] [Google Scholar]
  5. Dumont B, Castronovo V, Peulen O, et al. Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis. J Proteome Res 2012 ; 11 : 2247–2260. [CrossRef] [PubMed] [Google Scholar]
  6. Merline R, Schaefer RM, Schaefer L. The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal 2009 ; 3 : 323–335. [CrossRef] [PubMed] [Google Scholar]
  7. Kou I, Nakajima M, Ikegawa S. Expression and regulation of the osteoarthritis-associated protein asporin. J Biol Chem 2007 ; 282 : 32193–32199. [CrossRef] [PubMed] [Google Scholar]
  8. Maris P, Blomme A, Palacios AP, et al. Asporin is a fibroblast-derived TGF-β1 inhibitor and a tumor suppressor associated with good prognosis in breast cancer. PLoS Med 2015 ; 12 : e1001871. [CrossRef] [PubMed] [Google Scholar]
  9. Moyret-Lalle C, Pommier R, Bouard C, et al. Plasticité des cellules cancéreuses et dissémination métastatique. Med Sci (Paris) 2016 ; 32 : 725–731. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  10. Giavazzi R, Garofalo A, Bani MR, et al. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 1990 ; 50 : 4771–4775. [Google Scholar]
  11. Reed JR, Leon RP, Hall MK, Schwertfeger KL. Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. Breast Cancer Res 2009 ; 11 : R21. [CrossRef] [PubMed] [Google Scholar]
  12. Hong DS, Hui D, Bruera E, et al. MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study. Lancet Oncol 2014 ; 15 : 656–666. [CrossRef] [PubMed] [Google Scholar]
  13. Özdemir BC, Pentcheva-Hoang T, Carstens JL, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 2014 ; 25 : 719–734. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.